text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 498-02-2 | Product Number: H0261

4'-Hydroxy-3'-methoxyacetophenone


Purity: >98.0%(GC)
Synonyms:
  • Acetovanillone
  • Apocynin
Product Documents:
25G
€51.00
3   ≥100 
100G
€178.00
Contact Us ≥100 

*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).


Product Number H0261
Purity / Analysis Method >98.0%(GC)
Molecular Formula / Molecular Weight C__9H__1__0O__3 = 166.18 
Physical State (20 deg.C) Solid
Storage Temperature Room Temperature (Recommended in a cool and dark place, <15°C)
CAS RN 498-02-2
Reaxys Registry Number 637373
PubChem Substance ID 87570688
SDBS (AIST Spectral DB) 6357
Merck Index (14) 741
MDL Number

MFCD00008747

Specifications
Appearance White to Yellow to Orange powder to crystal
Purity(GC) min. 98.0 %
Melting point 113.0 to 117.0 °C
Solubility in Methanol faint turbidity
Properties (reference)
Melting Point 115 °C
Boiling Point 300 °C
Maximum Absorption Wavelength 383(MeOH) nm
GHS
Pictogram Pictogram
Signal Word Warning
Hazard Statements H315 : Causes skin irritation.
H319 : Causes serious eye irritation.
Precautionary Statements P264 : Wash skin thoroughly after handling.
P280 : Wear protective gloves/ eye protection/ face protection.
P302 + P352 : IF ON SKIN: Wash with plenty of water.
P337 + P313 : If eye irritation persists: Get medical advice/ attention.
P362 + P364 : Take off contaminated clothing and wash it before reuse.
P332 + P313 : If skin irritation occurs: Get medical advice/ attention.
Related Laws:
EC Number 207-854-5
RTECS# AM8800000
Transport Information:
HS Number 2914500090
Application
Apocynin: A Selective Inhibitor of NADPH Oxidase Activity

Apocynin, a methoxy-substituted catechol analog, is contained in the traditional medicinal plant Picrorhiza kurroa which has been used for the treatment of liver and heart problems. Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase is an enzyme that effectively reduces O2 to superoxide anion radical (O2) by transferring one electron to oxygen from NADPH. The superoxide anion radical can be used by the immune system to kill bacteria and fungi. It has been reported that apocynin acts as an inhibitor of NADPH oxidase activity, and can decrease the production of superoxide anion radical from activated neutrophils and macrophages. The production of superoxide anion radical has also been shown to be associated with inflammation. Acutually, the anti-inflammatory activity of apocynin has been demonstrated in a variety of cell and animal models of inflammation. (A related compound: NADPH. 3Na Salt [T0521]) (The product is for research purpose only.)

References


PubMed Literature


TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.

The requested SDS is not available.

Please Contact Us for more information.

Specifications
C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The product with the lot number searched for has been discontinued and no related documentation is available.

Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.

A sample C of A for this product is not available at this time.

Analytical Charts
Please enter Lot Number Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.

The requested analytical chart is not available. Sorry for the inconvenience.

The product with the lot number searched for has been discontinued and no related documentation is available.

Other Documents

Session Status
Your session will timeout in 10 minutes. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page. minute. You will be redirected to the HOME page after session timeout. Please click the button to continue session from the same page.

Your session has timed out. You will be redirected to the HOME page.